Home>
US Stocks>
Allogene Therapeutics

Allogene Therapeutics share price today

(ALLO)

Allogene Therapeutics share price is $2.09 & ₹178.06 as on 25 Dec 2024, 2.30 'hrs' IST

$2.09

▲

0.14

(7.18%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Allogene Therapeutics share price in Dollar and Rupees. Guide to invest in Allogene Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Allogene Therapeutics. Get details on the Indian mutual funds that are investing in Allogene Therapeutics. Get Analyst recommendations and forecasts along with all the Allogene Therapeutics's financials.

Allogene Therapeutics share price movements

Today's Low: $1.91
Today's High: $2.09
$2.09
8.61%
Downside
Day's Volatility :8.61%
Upside
0.0%
52 Weeks Low: $1.78
52 Weeks High: $5.78
$2.09
14.83%
Downside
52 Weeks Volatility :69.18%
Upside
63.81%

Allogene Therapeutics Returns

Period	Allogene Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-23.16%	-9.0%	0.0%
6 Months	-14.34%	-4.6%	0.0%
1 Year	-34.69%	3.0%	0.0%
3 Years	-86.43%	0.0%	-21.1%

Allogene Therapeutics Key Statistics

in dollars & INR

Previous Close	$1.95
Open	$1.94
Today's High	$2.09
Today's Low	$1.91
Market Capitalization	$438.2M
Today's Volume	$1.8M
52 Week High	$5.775
52 Week Low	$1.78
Revenue TTM	$43.0K
EBITDA	$-255.0M
Earnings Per Share (EPS)	$-1.55
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-54.15%

How to invest in Allogene Therapeutics from India?

It is very easy for Indian residents to invest directly in Allogene Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Allogene Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Allogene Therapeutics or ALLO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Allogene Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Allogene Therapeutics shares which would translate to 0.408 fractional shares of Allogene Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Allogene Therapeutics, in just a few clicks!

Returns in Allogene Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Allogene Therapeutics investment value today

Current value as on today

₹67,551

Returns

₹32,449

(-32.45%)

Returns from Allogene Therapeutics Stock

₹34,688 (-34.69%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Allogene Therapeutics

89%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Allogene Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 89% more investors are searching Allogene Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Allogene Therapeutics

FMR Inc
14.32%
TPG GP A, LLC
8.93%
BlackRock Inc
7.84%
Vanguard Group Inc
3.97%
State Street Corp
3.34%
Capital World Investors
3.29%

Analyst Recommendation on Allogene Therapeutics

Buy

73%Buy

26%Hold

0%Sell

Based on 23 Wall street analysts offering stock ratings for Allogene Therapeutics(by analysts ranked 0 to 5 stars)

Based on 23 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Allogene Therapeutics

What analysts predicted

Upside of 332.62%

Current:

$2.09

Target:

$9.04

Insights on Allogene Therapeutics

Price Movement
In the last 7 days, ALLO stock has moved up by 13.6%
Increasing Revenue
Revenue is up for the last 2 quarters, 21.0K → 22.0K (in $), with an average increase of 4.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -66.35M → -66.29M (in $), with an average increase of 0.1% per quarter
ALLO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 59.3%
ALLO vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 111.9%

Allogene Therapeutics Technicals Summary

Sell

Neutral

Buy

Allogene Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Allogene Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Allogene Therapeutics, Inc.	-17.06%	-14.34%	-34.69%	-86.43%	-91.95%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Allogene Therapeutics, Inc.	NA	NA	NA	-1.31	-0.54	-0.26	NA	2.21
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Allogene Therapeutics, Inc.	Buy	$438.2M	-91.95%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Allogene Therapeutics

allogene therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor t-cell (car t) therapy directed at blood cancers and solid tumors. founded and led by former kite pharma executives who bring unrivaled clinical development acumen in cell therapy, allogene is well-positioned to further the potential of allogeneic cell therapy for patients. allogeneic car t therapies are engineered from cells of healthy donors and stored for “off-the-shelf” use in patients. this approach eliminates the need to create personalized therapy from a patient’s own cells, simplifies manufacturing, and reduces the time patients must wait for car t treatment. the allogene portfolio includes 16 pre-clinical t cell therapy assets and ucart19, an allogeneic car t therapy currently in phase 1 development for the treatment of acute lymphoblastic leukemia (all). through its notable partnerships, allogene le

Organization	Allogene Therapeutics
Employees	232
CEO	Dr. Arie S. Belldegrun F.A.C.S., M.D.
Industry	Health Technology

Management People of Allogene Therapeutics

Name	Title
Dr. Arie S. Belldegrun F.A.C.S., M.D.	Co-Founder & Executive Chairman
Dr. David D. Chang M.D., Ph.D.	Co-Founder, President, CEO & Director
Mr. Joshua A. Kazam	Co-Founder & Director
Mr. Timothy L. Moore Ph.D.	Executive VP & Chief Technical Officer
Dr. Zachary J. Roberts M.D., Ph.D.	Executive VP of Research & Development and Chief Medical Officer
Mr. Geoffrey M. Parker	Executive VP & CFO
Ms. Annie Yoshiyama	Senior VP, Corporate Controller & Principal Accounting Officer
Mr. Earl M. Douglas Esq.	Senior VP, General Counsel, Compliance Officer & Corporate Secretary
Ms. Susan R. Lundeen	Chief People Officer
Ms. Christine Cassiano	Executive VP, Chief Corporate Affairs & Brand Strategy Officer

Important FAQs about investing in Allogene Therapeutics from India :

What is Allogene Therapeutics share price today?

Allogene Therapeutics share price today stands at $2.09, Open: $1.94 ; Previous Close: $1.95 ; High: $2.09 ; Low: $1.91 ; 52 Week High: $5.78 ; 52 Week Low: $1.78. The stock opens at $1.94, after a previous close of $1.95. The stock reached a daily high of $2.09 and a low of $1.91, with a 52-week high of $5.78 and a 52-week low of $1.78.

Can Indians buy Allogene Therapeutics shares?

Yes, Indians can invest in the Allogene Therapeutics (ALLO) from India.

With INDmoney, you can buy Allogene Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Allogene Therapeutics at zero transaction cost.

How can I buy Allogene Therapeutics shares from India?

It is very easy to buy Allogene Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Allogene Therapeutics be purchased?

Yes, you can buy fractional shares of Allogene Therapeutics with INDmoney app.

What are the documents required to start investing in Allogene Therapeutics stocks?

To start investing in Allogene Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.